Skip to search formSkip to main contentSkip to account menu

KRI 1314

Known as: KRI-1314 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

DipeptidesMorpholinesNaphthalenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Die gegenwärtige Methodik der Behandlung der Lungentuberkulose in einem Vergleich zwischen den USA, Großbritannien und Deutschland
In allen L~ndern der Welt gibb es eine tuberkulfse Infektion und gibt es Erkrankungen der Atmungsorgane, die yon dem… 
1996
1996
Synthesis and renin inhibitory activity of novel angiotensinogen transition state analogues modified at the P(2)-histidine position.
1994
1994
[Hypotensive action of human renin inhibitor KRI-1314 in the common marmoset].
The possibility of using KRI-1314, a new cyclohexylnorstatine derivative, as an antihypertensive drug was examined using common… 
1994
1994
Hypotensive action of a selective renin inhibitor, KRI-1314, in Goldblatt hypertensive marmosets
1993
1993
KRI-1314: an orally effective inhibitor of human renin.
Biochemical and pharmacological properties of KRI-1314, a newly synthesized, low molecular weight (M.W.: 690) renin inhibitor… 
1993
1993
KRI-1314 : an orally effective inhibitor of human renin
1992
1992
Local generation and action of angiotensin II in dog iris sphincter muscle.
1992
1992
The effect of intravenous recombinant human renin on blood pressure in pithed spontaneously hypertensive rats.
1991
1991
Direct proof for local generation and release of angiotensin II in peripheral human vascular tissue.
Previously we reported that immunoreactive angiotensin II (Ang II) release from isolated perfused human umbilical veins was… 
1989
1989
An orally active renin inhibitor: cyclohexylnorstatine-containing dipeptide (KRI-1314)
In our continuing search for low molecular weight, human renin inhibitors, a dipeptide derivative, morpholino-naphthyl-acyl… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)